Phase Ib of Sorafenib in Combination With Everolimus in Patients With Advanced Solid Tumors, Selected on the Basis of Molecular Targets

BACKGROUND. Molecular alterations of the PI3K and Ras pathways often occur in human cancer. In this trial, the pharmacokinetics, toxicity, and activity of two drugs inhibiting these pathways—everolimus and sorafenib—were investigated. METHODS. Thirteen patients with progressing solid tumors were tre...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Toffalorio, Francesca, Spitaleri, Gianluca, Catania, Chiara, Dal Zotto, Laura, Noberasco, Cristina, Delmonte, Angelo, Santarpia, Mariacarmela, Vecchio, Fabio, Brunelli, Veronica, Rampinelli, Cristiano, Barberis, Massimo, Fumagalli, Caterina, Zucchetti, Massimo, Zangarini, Monique, Diena, Tullia, Danesi, Romano, de Braud, Filippo, De Pas, Tommaso
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AlphaMed Press 2014
Onderwerpen:
Clinical Trial Results
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3983818/
https://ncbi.nlm.nih.gov/pubmed/24674875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0335
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items